Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Telomere shortening limits the number of cell divisions of primary human cells and might affect the regenerative capacity of organ systems during aging and chronic disease. To test whether the telomere hypothesis applies to human cirrhosis, the telomere length was monitored in cirrhosis induced by a broad variety of different etiologies. Telomeres were significantly shorter in cirrhosis compared with noncirrhotic samples independent of the primary etiology and independent of the age of the patients. Quantitative fluorescence in situ hybridization showed that telomere shortening was restricted to hepatocytes whereas lym‐phocytes and stellate cells in areas of fibrosis had significantly longer telomere reserves. Hepatocyte‐specific telomere shortening correlated with senescence‐associated p‐galactosidase staining in 84% of the cirrhosis samples, specifically in hepatocytes, but not in stellate cells or lymphocytes. Hepatocyte telomere shortening and senescence correlated with progression of fibrosis in cirrhosis samples. This study demonstrates for the first time that cell type‐specific telomere shortening and senescence are linked to progression of human cirrhosis. These findings give a novel explanation for the pathophysiology of cirrhosis, indicating that fibrotic scarring at the cirrhosis stage is a consequence of hepatocyte telomere shortening and senescence. The data imply that future therapies aiming to restore regenerative capacity during aging and chronic diseases will have to ensure efficient targeting of specific cell types within the affected organs.—Wiemann, S. U., Satyanarayana, A., Tsahuridu, M., Tillmann, H. L., Zender, L., Klempnauer, J., Flemming, P., Franco, S., Blasco, M. A., Manns, M. P., Rudolph, K. L. Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis. FASEB J. 16, 935–942 (2002)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Telomere shortening has been implicated in hepatocyte senescence94 and in disease progression in patients with liver cirrhosis95.”
From Telomere dysfunction in ageing and age-related diseases (2022) · cites this paper as [94]
In the citing paper
“Although less is known about hepatocyte senescence in humans than in mice, senescence-associated markers such as SA-β-gal staining have been identified in human cirrhotic livers160.”
From SenNet recommendations for detecting senescent cells in different tissues (2024) · cites this paper as [160]
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477 · cited 2×
“Senescence-associated -Gal staining was performed as described previously (18).”
BackgroundMethodTelomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750 · cited 1×
“Continuous shortening of telomeres during each cell division limits the life span of primary human cells in vitro (6).”
BackgroundHistological grading and staging of chronic hepatitis
Ishak, K., Baptista, A., Bianchi, L., Callea, F., De Groote, J., Gudat, F., Denk, H., Desmet, V., Korb, G., MacSween, R. N. M., et al. (1995) · Journal of Hepatology · doi:10.1016/0168-8278(95)80226-6 · Cited by 5,029 · cited 3×
“Cirrhosis samples were grouped into samples with mild fibrosis and samples with severe fibrosis according to the Ishak criteria (19).”
MethodInfluentialStructure and function of telomeres
Blackburn, E. H. (1991) · Nature · doi:10.1038/350569a0 · Cited by 3,596
The Cellular Basis of Hepatic Fibrosis -- Mechanisms and Treatment Strategies
Flier, J. S., Underhill, L. H., & Friedman, S. L. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306243282508 · Cited by 1,432
p53- and ATM-Dependent Apoptosis Induced by Telomeres Lacking TRF2
Karlseder, J., Broccoli, D., Dai, Y., Hardy, S., & de Lange, T. (1999) · Science · doi:10.1126/science.283.5406.1321 · Cited by 1,086 · cited 1×
“The tumor suppressor p53 has been identified as a downstream target of short dysfunctional telomeres in mouse (34) and human cells (35).”
BackgroundChin, L., Artandi, S. E., Shen, Q., Tam, A., Lee, S.-L., Gottlieb, G. J., Greider, C. W., & DePinho, R. A. (1999) · Cell · doi:10.1016/s0092-8674(00)80762-x · Cited by 979
Telomere Shortening Is Associated with Cell Division in Vitro and in Vivo
Allsopp, R. C., Chang, E., Kashefi-Aazam, M., Rogaev, E. I., Piatyszek, M. A., Shay, J. W., & Harley, C. B. (1995) · Experimental Cell Research · doi:10.1006/excr.1995.1306 · Cited by 533 · cited 2×
“It is still a matter of debate to what extent telomere shortening affects organo-pathophysiology during aging (7) or chronic diseases that induce elevated rates of cell turnover (8–11).”
BackgroundTelomere dysfunction and evolution of intestinal carcinoma in mice and humans
Rudolph, K. L., Millard, M., Bosenberg, M. W., & DePinho, R. A. (2001) · Nature Genetics · doi:10.1038/88871 · Cited by 527 · cited 1×
“It has been shown that telomere shortening inhibits tumorigenesis in mTERC / mice that retain functional p53 (17, 32, 33).”
BackgroundSelf-citationCurrent Protocols in Cell Biology
(2001) · John Wiley & Sons, Inc. eBooks · doi:10.1002/0471143030 · Cited by 502
Research works printed but not linked: 1
- Rudolph K. L., 2001, Telomeres and telomerase in experimental liver cirrhosis, The Liver Biology and Pathobiology, 1000
Cited by
Items 501–547 of 547
Laurent, G. (2003) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.1005304.195171
(2013) · AGE · doi:10.1007/11357.1574-4647
Stem cell regeneration in human liver
Roskams, T. (2007) · Springer eBooks · doi:10.1007/1-4020-3420-2_12
Cantz, T., Sharma, A. D., Manns, M. P., & Ott, M. (2016) · Springer eBooks · doi:10.1007/978-3-319-28386-9_5
Self-citationSharma, A. D., Iacob, R. A., Cantz, T., Manns, M. P., & Ott, M. (2013) · Springer eBooks · doi:10.1007/978-94-007-5690-8_37
Self-citationAlison, M. R. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.737501224.793572624
The telomere tango: Liver disease in the genomic spotlight
Schmidt, K. A., & Simonetto, D. A. (2023) · Hepatology · doi:10.1097/hep.0000000000000697
Role of autotaxin for the pathogenesis of liver fibrosis in biliary atresia
Udomsinprasert, W. (2016) · Chula Digiverse · doi:10.58837/chula.the.2016.1693
Hepatic functional deterioration in chronic liver disease
Tateishi, R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99698-3.00002-5
de l’Hortet, A. C. (2014) · theses.fr (ABES) · doi:10.70675/2a14549ezaf9fz40c0zbb4ez584cc4a4eb20
Gomes, W. R. (2024) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2024.tde-25072024-153611
Андреева, Д. И., Gazizov, I. M., Йылмаз, Т. С., Калигин, М. С., Gumerova, A. A., & Kiyasov, A. P. (2013) · Genes and Cells · doi:10.23868/gc120567
Liver regeneration following partial hepatectomy in hepatocellular carcinoma: not only size mattersPreprint
Long, H., Wu, Q., Huang, J., Zhong, X., Xie, Y., Duan, Y., Xie, W., Chen, Z., Li, D., Xie, X., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-5792291/v1
Molecular Basis for Hepatocellular Carcinoma Development in Low/Middle-Income Countries
Tabll, A. A., El‐maadawy, E. A., & Talaat, R. M. (2025) · Springer eBooks · doi:10.1007/978-981-96-3894-9_3
Anatomy and Physiology of the Biliary Epithelium
Hall, C., Glaser, S. S., & Alpini, G. D. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-95488-4.01004-4
Yağbasan, F. Ö., Demir, Y. D. Ş., & Ark, M. (2025) · Turkish Journal of Clinics and Laboratory · doi:10.18663/tjcl.1745156
Cellular Senescence Limits the Extent of Fibrosis Following Liver Damage
Krizhanovsky, V. (2013) · Springer eBooks · doi:10.1007/978-94-007-5958-9_25
Cancer Stem Cells in Hepatocellular Cancer
Langan, R. C., & Avital, I. (2011) · Humana Press eBooks · doi:10.1007/978-1-61779-246-5_10
Bone marrow derived stem cells for the treatment of end-stage liver disease.
Margini, C., VUKOTIC, R., Brodosi, L., BERNARDI, M., & Andreoné, P. (2014) · Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) · doi:10.3748/wjg.v20.i26.0000
Tometten, M., Kirschner, M., Isfort, S., Berres, M.-L., Brümmendorf, T. H., & Beier, F. (2021) · Figshare · doi:10.6084/m9.figshare.16682723
Tang, L., Li, D., Ma, Y., Cui, F., Wang, J., & Tian, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26637630
Automated Diagnosis of Liver Allograft Fibrosis using Machine Learning Approaches
Rabindranath, M. (2023) · TSpace (University of Toronto) · Cited by 1
Télomerase et destin des tumeurs neuroblastiques
Samy, M. (2010) · theses.fr (ABES) · doi:10.70675/07050b7dz1056z4e65za6f1z34cea95a398b · Cited by 2
Benkdane, M. (2012) · theses.fr (ABES) · doi:10.70675/45d1370fz6819z4b07zb446zd155483ab1de
Sénescence cellulaire et nouvelles approches thérapeutiques de l'hypertension artérielle pulmonaire
Mouraret, N. (2013) · theses.fr (ABES) · doi:10.70675/b2ae892dzafc0z4b55z9d55zb8908a6a07c7
Fibrosis : a key alteration of adipose tissue in obesity with metabolic consequences
Liu, Y. (2015) · theses.fr (ABES) · doi:10.70675/280936e6z0678z4ae9zb497z695bd191c58a · Cited by 1
Modulation de la sénescence induite par les oncogènes par les glucocorticoïdes et rôle de EGR1
Carvalho, C. (2018) · theses.fr (ABES) · doi:10.70675/7cafc6a4za30dz467dz81a1z7033a7846a52
Immaturité, sénescence et hiérarchie fonctionnelle des progéniteurs endothéliaux humains
Ferratge, S. (2016) · theses.fr (ABES) · doi:10.70675/1d6f719ez6992z424bza6adz9b7cc16bed52
Role of telomerase and β-catenin aberrant activation in benign and malignant liver tumorigenesis
Franconi, A. (2017) · theses.fr (ABES) · doi:10.70675/cb2ed566zf883z4e04zbeeezf786e3de915f
Farés, N. (2019) · theses.fr (ABES) · doi:10.70675/eef9404azffadz4212z9948z699104f7c1ab
Maintenance des télomères dans la carcinogenèse hépatique : fonction et transfert vers la clinique
Ningarhari, M. (2022) · theses.fr (ABES) · doi:10.70675/f313264az1d77z4572z8a2dz6fc821d54a58
Research progress in the anti-aging potential of neural stem cells
Wu, J.-C., Yang, J.-Y., Li, N., & Liu, J. (2025) · Nature Advance · doi:10.61958/natx7823
Telomeres in mitosis: organization and dynamics
Torre, M. L., Fabiano, S., Burla, R., & Saggio, I. (2026) · Nucleus · doi:10.1080/19491034.2026.2698214
“Dysfunctional telomeres have been associated with bone marrow failure, dys-keratosis congenita [62–64], aplastic anemia [65], pulmonary fibrosis [66,67], liver disease [68] and, in broader terms, with cancer (Figure 1(C)) [69–75].”
Aging, liver, and alcohol-associated liver disease
Liu, T., Zheng, Z., Sun, H., Wang, X., & Gao, Y. (2026) · Hepatobiliary Communications · doi:10.1016/j.hbc.2026.100005
ドナーテロメアやGテールの生体肝移植後の臨床所見に関する影響
Liu, B. O., & Liu, B. O. (2019) · Hiroshima University Institutional Repository
Yu, Y. (2026) · Journal of Food Science Nutrition and Health · doi:10.54254/3029-0821/2026.36667
Cell Senescence and the Aging Liver
Pisu, R., Laconi, E., & Marongiu, F. (2026) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl50660
López, Á., & Jesús, M. (2015) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) · Cited by 1
Galles, L. L. A. (2010) · UA Campus Repository (The University of Arizona)
Regenerative Therapies for Liver Diseases
Sharma, A. D., Rittelmeyer, I., Cantz, T., & Ott, M. (2012) · Humana Press eBooks · doi:10.1007/978-1-62703-098-4_10
“It has recently been shown that hepatocytes become senescent, owing at least partially to telomere shortening, in the cirrhotic stage of a wide variety of chronic human liver diseases [24, 25].”
Background
Metadata
- Authors
- WIEMANN, S. U., SATYANARAYANA, A., TSAHURIDU, M., TILLMANN, H. L., ZENDER, L., KLEMPNAUER, J., FLEMMING, P., FRANCO, S., BLASCO, M. A., MANNS, M. P., & RUDOLPH, K. L.
- Affiliations
- Medizinische Hochschule Hannover (DE)
- Department of Gastroenterology, Hepatology, and Endocrinology Medical School Hannover Germany
- Consejo Superior de Investigaciones Científicas (ES)
- Department of Immunology and Oncology Centro National de Biotecnologia/CSIC Madrid Spain
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2002-07
- Volume
- 16
- Issue
- 9
- Pages
- 935-942
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2166704790
- Cited by
- 527
- References
- 34
- Citations by year
- 2026: 4 · 2025: 15 · 2024: 22 · 2023: 23 · 2022: 20 · 2021: 28 · 2020: 35 · 2019: 17 · 2018: 29 · 2017: 22 · 2016: 24 · 2015: 18 · 2014: 30 · 2013: 20 · 2012: 20
- FWCI
- 7.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The FASEB Journal (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft (Ru 745/2-1, SFB 265/C5)
- Deutsche Krebshilfe (10-1809-Ru1)
- Ministerio de Ciencia y Tecnología
- European Commission
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Keywords
- telomere shortening, hepatocyte senescence, liver cirrhosis, liver fibrosis, senescence-associated β-galactosidase, hepatocytes, hepatic stellate cells, lymphocytes, telomere length, cirrhosis progression, regenerative capacity, aging
- MeSH terms
- Adolescent, Adult, Age Factors, Aged, beta-Galactosidase, Child, Humans, Liver Cirrhosis, Middle Aged, Models, Biological, Biomarkers, Telomere, Cellular Senescence, Disease Progression, Hepatocytes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.